Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

новая папка / Operative Standards for Cancer Surgery Volume I 1st Edition

.pdf
Скачиваний:
1
Добавлен:
15.11.2022
Размер:
11.32 Mб
Скачать

REFERENCES

1.Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest 2013;143(5)(suppl):e211S-e250S.

2.De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007;32(1):1-8.

3.Cornwell LD, Bakaeen FG, Lan CK, et al. Endobronchial ultrasonography-guided transbronchial needle aspiration biopsy for preoperative nodal staging of lung cancer in a veteran population. JAMA Surg 2013;148(11):1024-1029.

4.Herth FJ, Eberhardt R, Krasnik M, et al. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest 2008;133(4):887-891.

5.Herth FJ, Ernst A, Eberhardt R, et al. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 2006;28(5): 910-914.

6.Hwangbo B, Kim SK, Lee HS, et al. Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009;135(5):1280-1287.

7.Lee HS, Lee GK, Lee HS, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of nonsmall cell lung cancer: how many aspirations per target lymph node station? Chest 2008;134(2):368-374.

8.Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011;142(6):1393-1400.

9.Feller-Kopman D, Yung RC, Burroughs F, et al. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer 2009; 117(6):482-490.

10.Ømark Petersen H, Eckardt J, Hakami A, et al. The value of mediastinal staging with endobronchial ultrasound-guided transbronchial needle aspiration in patients with lung cancer. Eur J Cardiothorac Surg 2009;36(3):465-468.

11.Sanz-Santos J, Andreo F, Castellà E, et al. Representativeness of nodal sampling with endobronchial ultrasonography in non-small-cell lung cancer staging. Ultrasound Med Biol 2012;38(1): 62-68.

P.113

12.Nakajima T, Yasufuku K, Saegusa F, et al. Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in patients with lung cancer. Ann Thorac Surg 2013;95(5):1695-1699.

13.Jhun BW, Park HY, Jeon K, et al. Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer. J Korean Med Sci 2012;27(1):46-51.

14.Szlubowski A, Kuzdzał J, Kołodziej M, et al. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging.

Eur J Cardiothorac Surg 2009;35(2):332-335.

15.Bauwens O, Dusart M, Pierard P, et al. Endobronchial ultrasound and value of PET for prediction of pathological results of mediastinal hot spots in lung cancer patients. Lung Cancer 2008;61(3):356-361.

16.Joseph M, Jones T, Lutterbie Y, et al. Rapid on-site pathologic evaluation does not increase the efficacy of endobronchial ultrasonographic biopsy for mediastinal staging. Ann Thorac Surg 2013;96(2):403-410.

17.Lee BE, Kletsman E, Rutledge JR, et al. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2012; 143(3):585-590.

18.Cerfolio RJ, Bryant AS, Eloubeidi MA, et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 2010;90(2):427-434.

19.Navani N, Brown JM, Nankivell M, et al. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for

subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med 2012;185(12):1316-

1322.

20.Kuo C-H, Chen H-C, Chung F-T, et al. Diagnostic value of EBUS-TBNA for lung cancer with nonenlarged lymph nodes: a study in a tuberculosis-endemic country. PLoS ONE 2011;6(2):e16877.

21.Hu Y, Puri V, Crabtree TD, et al. Attaining proficiency with endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Cardiovasc Surg 2013;146(6):1387-1392.

22.Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005;50(3):347-354.

23.Rintoul RC, Tournoy KG, El Daly H, et al. EBUS-TBNA for the clarification of PET positive intrathoracic lymph nodes-an international multi-centre experience. J Thorac Oncol 2009;4(1):44-48.

24.Cetinkaya E, Seyhan EC, Ozgul A, et al. Efficacy of convex probe endobronchial ultrasound (CPEBUS) assisted transbronchial needle aspiration for mediastinal staging in non-small cell lung cancer cases with mediastinal lymphadenopathy. Ann Thorac Cardiovasc Surg

2011;17(3):236-242.

25.Ernst A, Anantham D, Eberhardt R, et al. Diagnosis of mediastinal adenopathy—real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol 2008;3: 577-582.

26.Gu P, Zhao Y, Jiang L, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 2009;45(8):1389-1396.

27.Adams K, Shah PL, Edmonds L, et al. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.

28.Abu-Hijleh M, El-Sameed Y, Eldridge K, et al. Linear probe endobronchial ultrasound bronchoscopy with guided transbronchial needle aspiration (EBUS-TBNA) in the evaluation of mediastinal and hilar pathology: introducing the procedure to a teaching institution. Lung

2013;191(1):109-115.

29.Dong X, Qiu X, Liu Q, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the mediastinal staging of non-small cell lung cancer: a meta-analysis. Ann Thorac Surg 2013;96(4):1502-1507.

30.Whitson BA, Groth SS, Odell DD, et al. True negative predictive value of endobronchial ultrasound in lung cancer: are we being conservative enough? Ann Thorac Surg 2013;95(5):1689-1694.

31.Liberman M, Duranceau A, Grunenwald E, Martin J, Thiffault V, Khereba M, et al. New technique performed by using EUS access for biopsy of para-aortic (station 6) mediastinal lymph nodes without traversing the aorta. Gastrointest Endosc 2011;73(5):1048-1051.

32.Cerfolio RJ, Bryant AS, Eloubeidi MA. Accessing the aortopulmonary window (#5) and the para-aortic (#6) lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg 2007;84(3):940-945.

33.Szlubowski A, Zieliński M, Soja J, Annema JT, Sośnicki W, Jakubiak M, et al. A combined approach of endobronchial and endoscopic ultrasound-guided needle aspiration in the radiologically normal mediastinum in non-small-cell lung cancer staging-a prospective trial. Eur J Cardiothorac Surg 2010;37(5):1175-1179.

P.114

34.Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, Crook JE, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;299(5):540-546.

35.Hwangbo B, Lee GK, Lee HS, Lim KY, Lee SH, Kim HY, et al. Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest 2010;138(4):795-802.

36.Block MI. Transition from mediastinoscopy to endoscopic ultrasound for lung cancer staging. Ann Thorac Surg 2010;89:885-890.

37.Annema JT, van Meerbeeck JP, Rintoul RC, Dooms C, Deschepper E, Dekkers OM, et al. Mediastinoscopy vs endosonography for

mediastinal nodal staging of lung cancer: a randomized trial. JAMA 2010;304(20):2245-2252.

38.Herth FJ, Krasnik M, Kahn N, Eberhardt R, Ernst A. Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest 2010;138(4):790-794.

39.Zielinski M, Szlubowski A, Kołodziej M, Orzechowski S, Laczynska E, Pankowski J, et al. Comparison of endobronchial ultrasound and/or endoesophageal ultrasound with transcervical extended mediastinal lymphadenectomy for staging and restaging of non-small-cell lung cancer. J Thorac Oncol 2013;8(5):630-636.

40.Vilmann P, Krasnik M, Larsen SS, Jacobsen GK, Clementsen P. Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions. Endoscopy 2005;37(9):833-839.

41.Trisolini R, Cancellieri A, Tinelli C, et al. Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy: a randomized trial. Chest 2011;139:395-401.

42.Defranchi SA, Edell ES, Daniels CE, Prakash UB, Swanson KL, Utz JP, et al. Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration. Ann Thorac Surg 2010;90(6):1753-1757.

Chapter 7

Cervical Mediastinoscopy

CRITICAL ELEMENTS

Nodal Station Assessment

Patient Eligibility

Preparing for Complications

1. NODAL STATION ASSESSMENT

Recommendation: Cervical mediastinoscopy can be used to evaluate lymph node stations 2R, 2L, 4R, 4L, and

7.

Type of Data: Retrospective.

Strength of Recommendation: Weak.

Rationale

Lung cancer patients with stage IIIA (ipsilateral) or stage IIIB (contralateral) mediastinal node involvement have poor long-term survival. The mediastinal nodes should be assessed before lung resection in patients who have accessible mediastinal lymph nodes that are greater than 1.5 cm in diameter and/or that positron emission tomography findings reveal to be positive. Patients without these characteristics but who nevertheless have a high likelihood of mediastinal nodal involvement should also undergo mediastinal lymph node assessment before lung resection. Such patients include those with tumors larger than 3 cm in diameter, central tumors (involving the inner third of the lung), and/or tumors of specific histologic types (i.e., large cell, neuroendocrine, and small cell tumors and adenocarcinomas) and/or those with multiple lung lesions. Patients who have tumors with a maximum standardized uptake value greater than 4 and/or positive N1 nodes on positron emission tomography (PET) should also undergo mediastinoscopy to assess the mediastinal nodes.

P.116 Mediastinal lymph nodes can be assessed using endobronchial ultrasonography or cervical mediastinoscopy. Cervical mediastinoscopy can be used to evaluate lymph node stations 2R, 2L, 4R, 4L, and 7. Endobronchial ultrasonography can evaluate these stations as well as station 10 and the hilar nodes in stations 11 and 12. The technique chosen depends on the surgeon’s preference, institutional expertise, and the contraindications to cervical mediastinoscopy. A broad discussion of the available modalities is found in Chapter 5, Invasive Mediastinal Staging Overview.

2. PATIENT ELIGIBILITY

Recommendation: Caution and good surgical judgment should be exercised when offering cervical mediastinoscopy to patients with superior vena cava syndrome, abnormal anatomy, prior treatment to the operative field, and coagulopathy.

Type of Data: Retrospective.

Strength of Recommendation: Weak.

Rationale

Several authors have reported series of patients with superior vena cava (SVC) syndrome who underwent

cervical mediastinoscopy. In these three series, 1 of 14 (7%) patients, 5 of 80 (6%) patients, and 2 of 39 (5%) patients, respectively, had significant bleeding requiring sternotomies. Airway obstruction due to hematoma was a life-threatening complication in one series. No patients in the three series died from undergoing mediastinoscopy. This complication is higher than reported in large series of patients without SVC syndrome

undergoing this procedure.1,2,3

Anatomic characteristics that would exclude patients from mediastinoscopy include aortic arch aneurysm and innominate artery calcification, which increase the risk for stroke, and existing tracheostomy. Patients who have limited neck mobility, including those with ankylosing spondylitis, also would not be candidates for cervical mediastinoscopy.

Patients who have received remote neck and chest radiation, as well as those who have had recent adjuvant chemoor radiotherapy, are candidates for mediastinoscopy. Mediastinoscopy can be repeated in patients who have received radiotherapy and in patients who present with a second malignancy. However, these patients may have inseparable adhesions that make performing repeat mediastinoscopy difficult. In addition, the lymph node sampling of a repeat mediastinoscopy is less sensitive than that of the primary mediastinoscopy.

Prior median sternotomy for cardiac surgery is not a contraindication to mediastinoscopy. Cardiac surgery typically does not violate the dissection plan used for mediastinoscopy, and mediastinoscopy outcomes in patients who have or have not had previous cardiac surgery are similar.

Nevertheless, surgeons should exercise good surgical judgment before offering mediastinoscopy and then intraoperatively in patients who have SVC syndrome or who have already undergone mediastinoscopy, have received neck radiation, or have undergone median sternotomy.

P.117

3. PREPARING FOR COMPLICATIONS

Recommendation: Proper preparation of both the patient and the operating room team and the use of video mediastinoscopy are essential to effectively managing emergency complications during cervical mediastinoscopy.

Type of Data: Retrospective.

Strength of Recommendation: Weak.

Rationale

Although rare, complications during cervical mediastinoscopy have been described. To ensure the successful and safe completion of the procedure, the entire operative team must be prepared to manage any complications, and the patient should be properly positioned and draped. These precautions will result in better outcomes with less morbidity.

The patient should be supine, with a roll placed transversely beneath the shoulders. The neck should be extended maximally and the head supported. The trachea should be easily palpable. Once the patient is under general anesthesia, an arterial line or pulse oximeter is placed in the right upper extremity to detect prolonged compression of the innominate artery. The availability of blood for potential transfusion should be confirmed. The draping should include the neck and chest in the unlikely event of lifethreatening hemorrhage, airway injury, or pneumothorax requiring urgent intervention.

Plans for immediate emergent median sternotomy or thoracotomy in the event of hemorrhage or airway injury should be discussed during the preoperative time-out. All members of the nursing, circulating, and anesthesia teams must be aware of their roles in the event of an emergency situation.

To help ensure that all members of the operating room team are aware of what is happening surgically, video mediastinoscopy should be utilized so that all members of the surgery, anesthesia, and nursing teams can view the procedure simultaneously. However, video mediastinoscopy may not be feasible in all patients, as video mediastinoscopes, which are significantly larger than standard mediastinoscopes, may be too big to use in patients with limited space between the trachea and sternal notch and in patients with dense adhesions in this area. In these instances, a standard mediastinoscope must be used; therefore, both a video and standard mediastinoscope should be readily available. As only the surgeon is able to see the operative field with a standard mediastinoscope, proper communication is essential in the event of a complication.

Technical Aspects

Apart from issues of safety, studies have shown that video-assisted mediastinoscopy yields a higher number of lymph nodes than standard mediastinoscopy. However, owing to the larger size of the video instrument, video mediastinoscopy has been associated with slightly higher rates of recurrent nerve injury and pneumothorax. One recent report suggests that for patients with similar tumors, video mediastinoscopy not only yields a greater number of lymph nodes than standard mediastinoscopy but also far more frequently results in upstaging the disease. This results in fewer N2 false negatives undergoing surgery. The net effect is that patients who undergo video mediastinoscopy have better long-term survival than patients who undergo standard mediastinoscopy.

P.118 To successfully perform cervical mediastinoscopy, surgeons must know the anatomy of the innominate artery and vein, the aortic arch, the superior vena cava, the pulmonary artery, the azygous vein, the left recurrent nerve, the esophagus, and lymph node positions. Knowledge of this anatomy will result in an overall completion rate of 1%, including hemorrhage (0.3%), vocal cord dysfunction (0.5%), tracheal injury (0.01%), and

pneumothorax (0.09%).4 Other rare complications include incisional metastasis and chyle leak.

Prior to incision, the thyroid isthmus and either the innominate or carotid artery should be palpated to detect any vascular anomalies. Aberrant innominate artery and right common carotid artery originating from a common carotid trunk have been described. The incision (2 to 4 cm) should be made below the thyroid isthmus and above the sternal notch. The incision is carried down to the pretracheal fascia. Finger dissection between the anterior trachea and the pretracheal fascia is extended to the tracheal bifurcation and laterally along both sides of the trachea. Finger dissection should be used to lift the innominate artery off of the trachea, and the pretracheal plane should be opened digitally to access the paratracheal nodes. These nodes can often be palpated in both the left and right paratracheal spaces. The use of finger dissection may be responsible for the low incidence of recurrent nerve injury following mediastinoscopy. In a review of patients in whom vocal cord motion was monitored during mediastinoscopy, digital dissection of the anterior tracheal wall activated both recurrent nerves. Cautery in the left paratracheal plane activated the left recurrent nerve, but cautery in the subcarinal or right paratracheal space elicited little activity in the right recurrent nerve. The study’s findings suggest that recurrent

nerve injury is due to dissection and traction rather than cautery use.5

After the pretracheal plane has been opened, the mediastinoscope is inserted, and a suction dissector is used to open the subcarinal fascia.

After dissection has clearly revealed the lymph nodes in both the left and right paratracheal areas and in the subcarinal space, biopsy forceps can be used to sample these nodes. Several previous studies have reported that two to seven lymph nodes are sampled per procedure, but whether these studies were referencing individual

nodes or pieces of nodes is unknown.6,7,8,9 Interestingly, one study demonstrated that the volume of tissue sampled from a lymph node station was correlated with the presence of N2 disease. This study showed that

biopsy of a greater number of lymph node stations did not increase the chances of detecting N2 disease. The

author concluded that the larger volumes were taken from enlarged suspicious nodes.10

Catastrophic bleeding can be avoided by the use of aspiration, prior to biopsy, if there is any doubt as to the dissection of a lymph node. Lymph node stations 2R, 2L, 4R, 4L, and 7 should be subject to biopsy. The aortopulmonary window lymph nodes (stations 5 and 6) cannot be biopsied during standard mediastinoscopy.

Because mediastinoscopy is used to assess an area that has major vascular structures, hemostasis is necessary prior to closing the incision. The suction dissector can be used to control minor bleeding. In the event of major bleeding, the mediastinoscope should be left in place, and the area should be packed with gauze and hemostatic materials to control the bleeding. If these steps do not control the bleeding or if major vascular structures such as the pulmonary artery are injured, emergency median sternotomy or thoracotomy should be performed. In these cases, the preparatory measures discussed with the nursing and anesthesia teams prior to operation may be lifesaving. In Table 7-1, the reader will find a summary of significant publications on the utility, efficacy, and safety of cervical mediastinoscopy.

P.119

P.120

P.121

TABLE 7-1 Summary of Mediastinoscopy References

Author

Study

No. of

Main Question

Key Findings

Potential

 

Design

Patients

 

 

for Bias

Turna et al,

Retrospective

433

Is there a

VID had greater

Yes

201311

 

 

survival

sensitivity, accuracy,

 

 

 

 

difference

and negative

 

 

 

 

between VID

predictive value than

 

 

 

 

and MED?

MED. 5-year survival

 

 

 

 

 

was 40% for VID vs.

 

 

 

 

 

66% for MED.

 

Zakkar et

Literature

6,123

Is VID better

No randomized

 

al, 201212

review and

 

than

studies have

 

 

meta-analysis

 

conventional

compared VID and

 

 

 

 

MED?

conventional MED.

 

Kanzaki et

Retrospective

224

Which PET-

Patients with right

Yes

al, 201113

 

 

negative

upper lobe or right

 

 

 

 

patients have

middle lobe

 

 

 

 

occult

adenocarcinoma >3

 

 

 

 

metastases at

cm, and patients with

 

 

 

 

operation?

SUV >4 had

 

 

 

 

 

increased risk of

 

 

 

 

 

occult metastases.

 

Cho et al,

Retrospective

521

How does the

VID had a lower

Yes

 

 

 

 

 

 

20106

 

 

lymph node

complication rate,

 

 

 

 

access, positive

detected more

 

 

 

 

node detection

positive nodes, and

 

 

 

 

rate, and

accessed the same

 

 

 

 

complication rate

lymph node stations.

 

 

 

 

of VID compare

 

 

 

 

 

with those of

 

 

 

 

 

conventional

 

 

 

 

 

MED?

 

 

Yasufuku et

Prospective

153

Is EBUS or MED

The EBUS and MED

No

al, 20117

 

 

more sensitive in

had equal sensitivity

 

 

 

 

detecting

and negative

 

 

 

 

positive lymph

predictive values.

 

 

 

 

nodes?

 

 

Anraku et

Retrospective

645

Does VID or

VID accessed more

Yes

al, 20108

 

 

conventional

lymph node stations

 

 

 

 

MED access

than MED.

 

 

 

 

more lymph

 

 

 

 

 

node stations

 

 

 

 

 

and detect more

 

 

 

 

 

positive lymph

 

 

 

 

 

nodes?

 

 

Nelson et

Retrospective

567

Is biopsy sample

Biopsy sample volume

Yes

al, 201010

 

 

volume related

was a better predictor

 

 

 

 

to the detection

of metastatic disease

 

 

 

 

of metastatic

than was the total

 

 

 

 

disease?

number of stations

 

 

 

 

 

sampled.

 

Al-Sarraf et

Retrospective

153

Which PET-

Patients with central

Yes

al, 200814

 

 

negative

tumors or right upper

 

 

 

 

patients have

lobe tumors, N1

 

 

 

 

occult positive

positive nodes, and

 

 

 

 

nodes at MED?

nodes >1 cm on CT

 

 

 

 

 

are more likely to

 

 

 

 

 

have occult positive

 

 

 

 

 

mediastinal nodes.

 

Upadhyaya

Case report

1

 

 

 

et al,

 

 

 

 

 

200815

 

 

 

 

 

Marra et al,

Prospective

104

Is repeat MED

Repeat MED after

Yes

200816

 

 

safe after

induction

 

 

 

 

induction

chemotherapy is

 

 

 

 

 

 

 

 

 

 

chemotherapy?

possible in 98% of

 

 

 

 

 

patients.

 

Roberts et

Prospective

15

What is the

Blunt digital

No

al, 20075

 

 

cause of

dissection, not

 

 

 

 

laryngeal nerve

cautery, causes

 

 

 

 

injury during

recurrent nerve

 

 

 

 

MED?

activation during

 

 

 

 

 

MED.

 

Lee et al,

Retrospective

224

Which patients

Central tumors, high

Yes

200717

 

 

with negative

SUV,

 

 

 

 

PET findings

adenocarcinoma, and

 

 

 

 

have positive

large tumor size all

 

 

 

 

nodes at MED?

predicted positive

 

 

 

 

 

nodes at MED.

 

de Langen

Meta-

896 14

What PET-

5% PET-negative

No

et al,

analysis

studies

negative

mediastinal lymph

 

200618

 

 

mediastinal

nodes 10-15 mm were

 

 

 

 

lymph node size

positive with MED;

 

 

 

 

should lead to

21% of PET-negative

 

 

 

 

MED?

>1.5 were positive on

 

 

 

 

 

MED.

 

Fibia et al,

Retrospective

142

What

Adenocarcinoma and

Yes

200619

 

 

mediastinal

lymph nodes >1 cm

 

 

 

 

lymph node size

increased the risk for

 

 

 

 

predicts positive

positive mediastinal

 

 

 

 

mediastinal

lymph nodes.

 

 

 

 

lymph nodes?

 

 

Lemaire et

Retrospective

2,145

What

24% of cancer

Yes

al, 20064

 

 

percentage of

patients had positive

 

 

 

 

cancer patients

lymph nodes at MED.

 

 

 

 

have positive

The complication rate

 

 

 

 

lymph nodes at

was 1.07%, and the

 

 

 

 

MED, and what

mortality rate was

 

 

 

 

is the

0.05%.

 

 

 

 

procedure’s

 

 

 

 

 

complication

 

 

 

 

 

rate?

 

 

Stamatis et

Retrospective

279

Is repeat MED

Repeat MED not

Yes

al, 200520

 

 

safe?

possible in 2% and

 

 

 

 

 

minor complications in

 

 

 

 

 

3%.

 

Dosios et

Retrospective

39

Is MED safe in

MED had a diagnostic

Yes

al, 20053

 

 

patients with

accuracy of 97%.

 

 

 

 

SVC syndrome?

There was no

 

 

 

 

 

mortality but 8% had

 

 

 

 

 

major complications,

 

 

 

 

 

including hemorrhage

 

 

 

 

 

and airway

 

 

 

 

 

obstruction.

 

Kumar et al,

Retrospective

28

Is MED safe in

No complications

Yes

200321

 

 

patients who

were reported.

 

 

 

 

have undergone

 

 

 

 

 

cardiac surgery?

 

 

Venissac et

Retrospective

240

What does our

On average, VID

No

al, 20139

 

 

experience with

could be used to

 

 

 

 

VID reveal?

access 2.3 lymph

 

 

 

 

 

node stations and

 

 

 

 

 

biopsy 6 lymph nodes.

 

 

 

 

 

Two patients had

 

 

 

 

 

complications.

 

 

 

 

 

Staging after

 

 

 

 

 

thoracotomy remained

 

 

 

 

 

unchanged in 93.6%

 

 

 

 

 

of patients.

 

Le Pimpec

Case report

1

 

The patient had

 

Barthes et

 

 

 

chylothorax following

 

al, 200322

 

 

 

MED.

 

Qureshi et

Case report

1

 

Patient had right

 

al, 200223

 

 

 

common carotid

 

 

 

 

 

crossing trachea from

 

 

 

 

 

left-sided common

 

 

 

 

 

carotid trunk,

 

 

 

 

 

precluding MED.

 

Baltayiannis

Case report

1

 

The patient had

 

et al,

 

 

 

incisional metastasis

 

200224

 

 

 

following MED.

 

Mineo et al,

Retrospective

80

Is MED safe in

There was no

Yes

19992

 

 

patients with

mortality, but 6% of

 

 

 

 

SVC syndrome?

patients had

 

 

 

 

 

significant bleeding.

 

Jahangiri et

Retrospective

14

Is MED safe in

There was no

Yes

al, 19931

 

 

patients with

mortality, but 7% of

 

 

 

 

SVC syndrome?

patients had bleeding

 

Соседние файлы в папке новая папка